About SCI Pharmtech
SCI Pharmtech is a company based in Taoyuan City (Taiwan) founded in 1987. SCI Pharmtech operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
- Headquarter Taoyuan City, Taiwan
- Stage Public
- SectorsHealthcare
- Website sci-pharmtech.com.tw
- Legal Name Sci Pharmtech Corp.
- Annual Revenue$1.34 B-11.81as on Dec 31, 2025
- Net Profit$107.37 M-79.92as on Dec 31, 2025
- EBITDA$408.21 M-5.52as on Dec 31, 2025
IPO & Listings of SCI Pharmtech
SCI Pharmtech is a publicly listed company on the TWSE with ticker symbol 4119 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Jan 2004
- Listed onTT: 4119
- Listed entitySCI Pharmtech Corp.
- Exchange sectorHealth technology
- ISINTW0004119003
- Share price54.40 TWD (+1.49% on the day) · 2026-10-08
- Market capitalisation6,501,270,007.00 TWD
- Price to earnings108.5
- EPS (diluted, trailing year)0.50 TWD
- Dividend yield1.38%
- Volume (last session)118,464
Financials of SCI Pharmtech
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.34B TWD | 107.4M TWD | 408.2M TWD |
| 2024 | 1.52B TWD | 534.7M TWD | 432.1M TWD |
| 2023 | 1.20B TWD | 294.7M TWD | 305.6M TWD |
| 2022 | 899.7M TWD | 308.8M TWD | 209.6M TWD |
| 2021 | 864.2M TWD | 55.7M TWD | 137.4M TWD |
Detailed financial statements for SCI Pharmtech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of SCI Pharmtech
SCI Pharmtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| apicore.com | 2004 | Somerset, United States | $720,118 | 518 | APIs are manufactured and custom synthesis services are provided. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| bellenchem.com | 2007 | Beijing, China | $52.56M | – | APIs and intermediates are researched and manufactured, specializing in heterocycles. |
Detailed competitors of SCI Pharmtech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SCI Pharmtech
The website of SCI Pharmtech (sci-pharmtech.com.tw) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 18.2% vs previous month
Websites whose visitors overlap most with SCI Pharmtech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
fund.pchome.com.tw | fund.pchome.com.tw | 100% | – | – | – |
cmoney.com.tw | cmoney.com.tw | 100% | – | #2,564,895 | – |
| moneydj.com | 100% | 8.4M | #9,834 | View details | |
pwc.tw | pwc.tw | 59% | – | – | – |
ifa.ai | ifa.ai | 59% | – | #1,115,077 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for SCI Pharmtech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Sci Pharmtech
Complete news archive for SCI Pharmtech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to SCI Pharmtech
10 companies that operate in the same segment as SCI Pharmtech (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SCI Pharmtech
SCI Pharmtech was founded in 1987.
SCI Pharmtech is headquartered in Taoyuan City, Taiwan.
SCI Pharmtech, (a wholly owned subsidiary of Swiss-based Siegfried Group), is engaged in the development and manufacturing of APIs, advanced intermediates, and custom products. Their facilities are FDA, EDQM, KFDA and Taiwan TFDA inspected. Their portfolio had 10 APIs and several intermediates (as of September 2017). They also have capabilities to offer custom manufacturing solutions which include analytical method development and validation, process development, scale-up, and optimization, dossier preparation and filing, and impurity profiling and stability studies.
SCI Pharmtech's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Yes, SCI Pharmtech is publicly traded on TWSE under the ticker symbol 4119.